Of late healthcare firms have been flocking to Wall Street, betting on the booming stock market to take their business expansion to
WCG Clinical IPO: Here’s what you should know before investing in the stock
Categories
Biotechnology
Biogen (BIIB) Earnings Infographic: Q2 profit, revenue drop but top estimates
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however, came in
Absci IPO: Here’s all you need to know about bioengineering firm’s Nasdaq listing
Wall Street is probably going through the busiest phase since the recession, in terms of the number of businesses seeking to go
IPO News: Here’s what to know when Sera Prognostics goes public this week
The healthcare industry continues to grow at a rapid pace with diagnostic services playing an important role in this space. Women’s health
Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2021 earnings call dated Jun. 29, 2021 Corporate Participants: Tim Brons -- Executive Vice President, Vida Strategic Partners,
Thermo Fisher (TMO) stock can add value to your portfolio. Here’s why
For Thermo Fisher Scientific Inc. (NYSE: TMO), a leading player in the medical diagnostics and life sciences market, 2020 was a busy
Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development
IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a
IPO News: What to look for when Elevation Oncology makes its Wall Street debut
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly
BeyondSpring, Inc.(BYSI) Q1 2021 Earnings Call Transcript
BeyondSpring, Inc. (NASDAQ: BYSI) Q1 2021 earnings call dated Jun. 16, 2021 Corporate Participants: Ashley R. Robinson -- Media & Investor Relations of LifeSci
Is Merck (MRK) stock still a buy after losing the vaccine race?
After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the mass production
LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?
For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges posed by
Bio-Path Holdings, Inc. (BPTH) Q1 2021 Earnings Call Transcript
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q1 2021 earnings call dated May. 14, 2021 Corporate Participants: Will O'Connor -- Investor Relations, Stern Investor Relations, Inc.
ImmunoGen’s post-earnings dip could be a good buying opportunity
Earlier this week, biotech company ImmunoGen (NASDAQ: IMGN) reported mixed financial results for the first quarter of 2021, pushing the stock into
Veru Inc. (VERU) Q2 2021 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q2 2021 earnings call dated May. 12, 2021 Corporate Participants: Sam Fisch -- Director of Investor Relations Mitchell Steiner -- Chairman, President,
FibroGen Inc. (FGEN) Q1 2021 Earnings Call Transcript
FibroGen Inc. (NASDAQ: FGEN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy and Investor
Immunogen, Inc. (IMGN) Q1 2021 Earnings Call Transcript
Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
Regeneron Pharmaceuticals Inc. (REGN) Q1 2021 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Justin Holko -- Vice President, Investor Relations Leonard S.
Moderna (MRNA): COVID-19 vaccine helps company deliver first ever profitable quarter
Shares of Moderna Inc. (NASDAQ: MRNA) were down 3% in morning hours on Thursday despite the company reporting the first profitable quarter
CVS Health gets a shot in the arm from COVID care: Is the stock a buy?
After being hit by the virus-induced slowdown in store footfall initially, CVS Health Corporation (NYSE: CVS) has regained the lost momentum by
AbbVie (ABBV) Stock: Here’s what you need to know before investing
AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's flagship product